Abstract:Abstract Background Cell division cycle-associated 7 (CDCA7), as a member of the cell division cycle associated family, was reported to be aberrantly expressed in both solid tumors and hematological tumors, suggesting its essential role in promoting tumorigenesis. Hence, we aimed to explore its comprehensive roles of overall survival (OS) in clear cell renal cell carcinoma (ccRCC) and emphasize its associations with immunity. Methods The RNA sequencing data and corresponding clinical information were downloaded from The Cancer Genome Atlas (TCGA) database. Gene set enrichment analysis (GSEA) was adopted to explore CDCA7 associated signaling pathways. Univariate and multivariate Cox regression analyses were carried out to assess independent prognostic factors. Furthermore, roles of CDCA7 in human immunity were also investigated. Results Our results suggested that CDCA7 was overexpressed in ccRCC and its elevated expression was related to shorter OS (P < 0.01). Univariate and multivariate Cox regression analyses identified CDCA7 as an independent prognostic factor (both P < 0.05). The prognostic nomogram integrating CDCA7 expression level and clinicopathologic variables was constructed to predict 1-, 3- and 5-year OS. GSEA indicated that high CDCA7 expression was related to the apoptosis pathway, cell cycle pathway, JAK-STAT pathway, NOD like receptor pathway, P53 pathway, T cell receptor pathway and toll like receptor pathway, etc. Moreover, CDCA7 was significantly related to microsatellite instability (MSI, P < 0.001) and tumor mutational burden (TMB, P < 0.001). As for immunity, CDCA7 was remarkably associated with immune infiltration, tumor microenvironment, immune checkpoint molecules and immune pathways. Conclusions CDCA7 could serve as an independent prognostic factor for ccRCC and it was closely related to MSI, TMB, and immunity.

High Expression of CDCA7 Promotes Cell Proliferation, Migration, Invasion and Apoptosis in Non-Small-Cell Lung Cancer

MicroRNA Let-7C Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma

Loss of Cell Division Cycle‑associated 5 Promotes Cell Apoptosis by Activating DNA Damage Response in Clear Cell Renal Cell Carcinoma.

CDCA7 promotes lung adenocarcinoma proliferation via regulating the cell cycle

Cdca7l Promotes Hepatocellular Carcinoma Progression by Regulating the Cell Cycle

Overexpression of CDCA7 Predicts Poor Prognosis and Induces EZH2‐mediated Progression of Triple‐negative Breast Cancer

CCL21/CCR7 Prevents Apoptosis Via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells.

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer

Inhibition of CCR7 Promotes NF-κB-dependent Apoptosis and Suppresses Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

Silencing Of Cxcr7 Gene Represses Growth And Invasion And Induces Apoptosis In Colorectal Cancer Through Erk And Beta-Arrestin Pathways

MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer

Study the Effects of CDA-2 on Growth and Apoptosis of Human Non-Small Cell Lung Cancer Cells

Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non‐small cell lung cancer cells via p53‐p21 signaling pathway

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma

Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity

Cirs-7 Targeting Mir-7 Modulates The Progression Of Non-Small Cell Lung Cancer In A Manner Dependent On Nf-Kappa B Signalling

Ccl21/Ccr7 Promotes G(2)/M Phase Progression Via the Erk Pathway in Human Non-Small Cell Lung Cancer Cells

MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells Through Targeting BCL-2.